Parthenolide: pioneering new frontiers in hematological malignancies
Hematological malignancies are the fifth most prevalent cancer category in developed countries, presenting significant treatment challenges. The side effects of chemotherapy and its non-selective nature have led researchers to explore combination therapies to enhance efficacy and improve patient out...
Saved in:
| Main Authors: | Elmira Zarei, Ayda Zarei, Azadeh Omidkhoda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1534686/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intestinal metaplasia key molecules and UPP1 activation via Helicobacter pylori /NF-kB: drivers of malignant progression in gastric cancer
by: Xuyu Chen, et al.
Published: (2024-12-01) -
EFFECT OF THE PLASTIC COVER COLOR AND ELECTROCUTION IN SOME VEGETATIVE GROWTH INDICATORS AND PARTHENOLIDE CONTENT IN LEAVES OF TANACETUIM PARTHENUIM L PLANT.
by: Z. J. Al-Mousawi, et al.
Published: (2017-12-01) -
过表达整合素链接激酶通过NF-kB通路促进脑胶质瘤细胞的上皮间质转化
Published: (2016-01-01) -
The NF-κB signaling network in the life of T cells
by: Mark A. Daniels, et al.
Published: (2025-04-01) -
Parthenolide ameliorates glucocorticoid-induced inhibition of osteogenic differentiation and osteoporosis by activating ERK signaling pathway
by: Yanling Feng, et al.
Published: (2025-05-01)